Drug Company Protections Are Latest Stumbling Block for Nafta Rewrite By News March 22, 2019 Add Comment Edit Democrats say intellectual property provisions in the deal are a boon to the pharmaceutical industry and could undermine their push to make American health care more affordable. Share this post Related Posts‘Dr. Seuss’s Garden’ Yields a Deep-Sea Discovery, but It Already Faces ThreatsU.S. Readies $11 Billion in Tariffs on E.U.Devin Nunes Sues McClatchy Newspaper Chain, Alleging ‘Character Assassination’William Barr Says Mueller Report Will Be Public ‘Within a Week’Divided House Democrats Delay Budget Vote as Ideological Gap WidensFan’s Video, Shared by Trump, Plays to Base’s Sense of GrievanceFact Check of the Day: Fact-Checking Trump’s Family Separation Claim about Obama’s PolicyJustice Dept. Watchdog’s Review of Russia Inquiry Is Nearly Done, Barr Says
0 Response to "Drug Company Protections Are Latest Stumbling Block for Nafta Rewrite"
Post a Comment